Trial Profile
Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 05 Dec 2022 Status changed from active, no longer recruiting to completed.
- 01 Nov 2021 Status changed from recruiting to active, no longer recruiting.
- 09 Dec 2020 Planned End Date changed from 30 Apr 2020 to 30 Apr 2025.